The European Commission typically rules about two months after the CHMP nod. In trials, the top dose of orforglipron cut around 11% of body weight over 72 weeks.
Recap by typeshit. Full story at Quartz.
Women on CagriSema hit 20% weight loss far more often than on semaglutide alone, 68.7% vs 38.0%, though Novo calls the comparisons exploratory.
The Sugarfit co-founder and the doctor argue that managing weight on GLP-1 medications takes more than the drug by itself.
European Business Magazine says oral Wegovy has 1.5 million patients and about $843m in first-half sales, while semaglutide generics spread in India and Canada.
Rooney says the Ozempic rumors are wrong, that he is working to look better and be healthier, and that he has stopped drinking alcohol for a while.
Reuters reports on a growing field of developers racing into obesity drugs as competition gets tighter.
Fierce Pharma's weekly tracker, using IQVIA data via Citi and Jefferies, has Zepbound still far ahead at about 801.8K total scripts.
Loading…